Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVIGEN(avgn) -- Ignore unavailable to you. Want to Upgrade?

To: Jacques Tenzel who wrote (168)	11/17/1999 12:44:00 AM
From: Mike McFarland	Respond to of 228

Wonder who are the 40M investors...maybe the biotech drought is over. It has been brutally difficult for the smallest biotechs to raise money--this was really pretty spectacular...most of my companies don't even have a marketcap as big as that! Hopefully we will see some comments from the more informed biogurus here on SI, unless they're too busy daytrading this one. Plus, only I am rude enough to barge around on the thread of a stock that I don't even own. I just hate chasing things as they soar, it's a mental block...guess I'll never be a real trader unless I can get over that. Besides ASGT, and their upcoming journal, there are obviously other authoritative sources. I have piles of this stuff, but honestly, I spend an awful lot of time looking up things in textbook glossaries <g>. Inducible gene therapy systems look very slick to me...but I suspect those wont make headlines for a few years. Guess I'll settle for getting rich slowly, very slowly;-)